Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-103036
Filing Date
2024-09-03
Accepted
2024-09-03 18:20:06
Documents
2
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1573
2 EX-24.1 dyn-ex24_1.htm EX-24.1 12293
  Complete submission text file 0000950170-24-103036.txt   15298
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
Friedl-Naderer Johanna (Reporting) CIK: 0001915598 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39509 | Film No.: 241275406